Apollo Ingredients Limited is an India-based manufacturer and producer of healthcare solutions. The Company is engaged in the business of manufacturing, producing, importing, exporting and dealing in total healthcare solutions in ayurvedic, homeopathic and allopathic medicines. It also carries out medical and clinical audits, medical, healthcare, and hospital facility planning from concept to commissioning and post commissioning managing healthcare institutions of any kind, public or private. The Company’s business also includes establishing and running hospitals/healthcare institutions, diagnostic centers, health spas, wellness centers, pathology, life science and stem cell depositories. It also provides support services such as housekeeping, security, technical and clinical, paramedical and nursing human resources to healthcare and other organizations. It launches hospitals and develops strategic concepts and business development policies for healthcare and health solutions.
Apollo Ingredients Limited Financial Highlights
- Revenue: Apollo Ingredients Limited reported revenue of ₹5.03 crore in FY26 vs ₹3.08 crore in FY25. It showed an increase of 63.31% on a yearly basis.
- Operating Profit: Apollo Ingredients Limited reported an operating profit of ₹0.95 crore in FY26 vs ₹0.13 crore in FY25. It showed an increase of 630.77% on a year-on-year basis.
- Net Profit: Apollo Ingredients Limited reported a net profit of ₹0.71 crore in FY26 vs ₹0.10 crore in FY25. It showed an increase of 610.00% on a yearly basis.
Apollo Ingredients Limited Quarterly Result Highlights
- Apollo Ingredients Limited reported revenue of ₹1.08 crore in Mar 2026, compared with ₹2.77 crore in Dec 2025, representing a decrease of 61.01% on a quarter-on-quarter (QoQ) basis.
- Apollo Ingredients Limited reported an operating profit of ₹0.07 crore in Mar 2026, compared with ₹0.87 crore in Dec 2025, representing a decrease of 91.95% on a quarter-on-quarter (QoQ) basis.
- Apollo Ingredients Limited reported a profit of ₹0.07 crore in Mar 2026, compared with ₹0.87 crore in Dec 2025, reflecting a decrease of 91.95% on a QoQ basis.
- The earnings per share (EPS) of Apollo Ingredients Limited stood at ₹0.68 during Mar 2026.
